Stanley L. Gaul

1.2k citations

24 papers · 871 indexed · h-index 16

Co-authors: David D. Wood Walfred S. Saari Rodney A. Bednar J C Quintero J A O'Brien Mark E. Goldman John Wai Jack H. Nunberg
Topics: Platelet Disorders and Treatments (7 papers)Heparin-Induced Thrombocytopenia and Thrombosis (4 papers)Neuroscience and Neuropharmacology Research (4 papers)
Cited by: Virology Infectious Diseases Hematology
Journals: Proceedings of the National Academy of Sciences The Journal of Immunology Biochemistry
Partner nations: United States

In The Last Decade

Stanley L. Gaul

24 papers receiving 813 citations

Peers

Countries citing papers authored by Stanley L. Gaul

Since Specialization

Citations

This map shows the geographic impact of Stanley L. Gaul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanley L. Gaul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanley L. Gaul more than expected).

Fields of papers citing papers by Stanley L. Gaul

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanley L. Gaul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanley L. Gaul. The network helps show where Stanley L. Gaul may publish in the future.

Co-authorship network of co-authors of Stanley L. Gaul

This figure shows the co-authorship network connecting the top 25 collaborators of Stanley L. Gaul. A scholar is included among the top collaborators of Stanley L. Gaul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stanley L. Gaul. Stanley L. Gaul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preclinical pharmacology and pharmacokinetics of CERC‐301, a GluN2B‐selectiveN‐methyl‐D‐aspartate receptor antagonist 2015 ·Pharmacology Research & Perspectives ·Rachel M. Garner,Shobha Gopalakrishnan,John A. McCauley,Rodney A. Bednar,Stanley L. Gaul,Scott D. Mosser,Laszlo Kiss,Joseph J. Lynch,Shil Patel,Christine Fandozzi,Armando Lagrutta,Richard J. Briscoe,Nigel J. Liverton,Blake Paterson,James J. Vornov,Reza Mazhari	37
2	Synthesis and evaluation of novel tricyclic benzo[4.5]cyclohepta[1.2]pyridine derivatives as NMDA/NR2B antagonists 2009 ·Bioorganic & Medicinal Chemistry Letters ·Charles McIntyre,John A. McCauley,Bohumil Bednář,Rodney A. Bednar,John W. Butcher,David A. Claremon,Michael E. Cunningham,Roger Freidinger,Stanley L. Gaul,Carl F. Homnick,Ken S. Koblan,Scott D. Mosser,Joseph J. Romano,Nigel J. Liverton	6
3	Cyclic benzamidines as orally efficacious NR2B-selective NMDA receptor antagonists 2007 ·Bioorganic & Medicinal Chemistry Letters ·Kevin T. Nguyen,Christopher F. Claiborne,John A. McCauley,Brian E. Libby,David A. Claremon,Rodney A. Bednar,Scott D. Mosser,Stanley L. Gaul,Thomas Connolly,Cindra Condra,Bohumil Bednář,Gary L. Stump,Joseph J. Lynch,Kenneth S. Koblan,Nigel J. Liverton	19
4	Identification and Characterization of 4-Methylbenzyl 4-[(Pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate, an Orally Bioavailable, Brain Penetrant NR2B SelectiveN-Methyl-d-Aspartate Receptor Antagonist 2007 ·Journal of Medicinal Chemistry ·Nigel J. Liverton,Rodney A. Bednar,Bohumil Bednář,John W. Butcher,Christopher F. Claiborne,David A. Claremon,Michael E. Cunningham,Anthony G. DiLella,Stanley L. Gaul,Brian E. Libby,Elizabeth A. Lyle,Joseph J. Lynch,John A. McCauley,Scott D. Mosser,Kevin T. Nguyen,Gary L. Stump,Hong Sun,Hao Wang,James A. Yergey,Kenneth S. Koblan	32
5	Automation of In Vitro Dose-Inhibition Assays Utilizing the Tecan Genesis and an Integrated Software Package to Support the Drug Discovery Process 2003 ·JALA Journal of the Association for Laboratory Automation ·Scott D. Mosser,Stanley L. Gaul,Bohumil Bednář,Kenneth S. Koblan,Rodney A. Bednar	1
6	Discovery of a nonpeptidic small molecule antagonist of the human platelet thrombin receptor (PAR-1) 2002 ·Bioorganic & Medicinal Chemistry Letters ·Philippe G. Nantermet,James C. Barrow,G. F. Lundell,(unknown),Kenneth E. Rittle,(unknown),Roger Freidinger,Thomas Connolly,Cindra Condra,Jerzy Karczewski,Rodney A. Bednar,Stanley L. Gaul,Robert J. Gould,(unknown),Harold G. Selnick	32
7	Discovery and initial structure–Activity relationships of trisubstituted ureas as thrombin receptor (PAR-1) antagonists 2001 ·Bioorganic & Medicinal Chemistry Letters ·James C. Barrow,Philippe G. Nantermet,Harold G. Selnick,(unknown),(unknown),Mary Beth Young,(unknown),Michael J. Breslin,John H. Hutchinson,Roger Freidinger,Cindra Condra,Jerzy Karczewski,Rodney A. Bednar,Stanley L. Gaul,Andrew M. Stern,Robert J. Gould,Thomas Connolly	17
8	Non-Peptide GPIIb/IIIa Inhibitors. 20. Centrally Constrained Thienothiophene α-Sulfonamides Are Potent, Long Acting in Vivo Inhibitors of Platelet Aggregation 1999 ·Journal of Medicinal Chemistry ·Melissa S. Egbertson,Jacquelynn J. Cook,Bohumil Bednář,John D. Prugh,Rodney A. Bednar,Stanley L. Gaul,Robert J. Gould,George D. Hartman,Carl F. Homnick,Marie A. Holahan,Laura A. Libby,Joseph J. Lynch,Robert J. Lynch,Gary R. Sitko,Maria T. Stranieri,(unknown)	2
9	Non-Peptide GPIIb/IIIa Inhibitors. 20. Centrally Constrained Thienothiophene α-Sulfonamides Are Potent, Long Acting in Vivo Inhibitors of Platelet Aggregation 1999 ·Journal of Medicinal Chemistry ·Melissa S. Egbertson,Jacquelynn J. Cook,Bohumil Bednář,John D. Prugh,Rodney A. Bednar,Stanley L. Gaul,Robert J. Gould,George D. Hartman,Carl F. Homnick,Marie A. Holahan,Laura A. Libby,Joseph J. Lynch,Robert J. Lynch,Gary R. Sitko,Maria T. Stranieri,(unknown)	41
10	Nonpeptide GPIIB/IIIA inhibitors. 16. Thieno[2,3-b]thiophene α-sulfonamides are potent inhibitors of platelet aggregation 1997 ·Bioorganic & Medicinal Chemistry Letters ·John D. Prugh,Robert J. Gould,Robert J. Lynch,Guixiang Zhang,Jacquelynn J. Cook,Marie A. Holahan,Maria T. Stranieri,Gary R. Sitko,Stanley L. Gaul,Rodney A. Bednar,Bohumil Bednář,George D. Hartman	9
11	Non-Peptide Glycoprotein IIb/IIIa Inhibitors. 17. Design and Synthesis of Orally Active, Long-Acting Non-Peptide Fibrinogen Receptor Antagonists 1997 ·Journal of Medicinal Chemistry ·(unknown),Rodney A. Bednar,Bohumil Bednář,David A. Claremon,Jacquelynn J. Cook,Charles McIntyre,(unknown),Robert J. Gould,Robert J. Lynch,Joseph J. Lynch,Stanley L. Gaul,Maria T. Stranieri,Gary R. Sitko,Marie A. Holahan,(unknown),(unknown),Lynn M. Gorham,Thomayant Prueksaritanont,John J. Baldwin,George D. Hartman	49
12	Nonpeptide GPIIb/IIIa inhibitors. 10. Centrally constrained alpha-sulfonamides are potent inhibitors of platelet aggregation 1996 ·Bioorganic & Medicinal Chemistry Letters ·Melissa S. Egbertson,George D. Hartman,R J Gould,Bohumil Bednář,Rodney A. Bednar,Jacquelynn J. Cook,Stanley L. Gaul,Marie A. Holahan,Laura A. Libby,Joseph J. Lynch,Robert J. Lynch,Gary R. Sitko,Maria T. Stranieri,(unknown)	34
13	Transglutaminase Inhibition by 2-[(2-Oxopropyl)thio]imidazolium Derivatives: Mechanism of Factor XIIIa Inactivation 1994 ·Biochemistry ·(unknown),(unknown),Stanley L. Gaul,David A. Claremon,David C. Remy,John J. Baldwin,Steven M. Pitzenberger,Andrew M. Stern	91
14	Identification and Characterization of Endothelin Converting Activity from EAHY-926 Cells: Evidence for the Physiologically Relevant Human Enzyme 1994 ·Archives of Biochemistry and Biophysics ·Lloyd Waxman,(unknown),Stanley L. Gaul,(unknown),Rodney A. Bednar,Andrew M. Stern	31
15	Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity. 1991 ·Proceedings of the National Academy of Sciences ·Mark E. Goldman,Jack H. Nunberg,J A O'Brien,J C Quintero,William A. Schleif,(unknown),Stanley L. Gaul,Walfred S. Saari,John Wai,J. M. HOFFMAN	256
16	Comparative Effects of Enalapril, Enalaprilic Acid and Captopril in Blocking Angiotensin I-Induced Pressor and Dipsogenic Responses in Spontaneously Hypertensive Rats 1984 ·Clinical and Experimental Hypertension Part A Theory and Practice ·Stanley L. Gaul,Gregory E. Martin,Charles S. Sweet	10
17	3-Hydroxy-.alpha.-methyltyrosine progenitors, synthesis and evaluation of some (2-oxo-1,3-dioxol-4-yl)methyl esters 1984 ·Journal of Medicinal Chemistry ·Walfred S. Saari,Wasyl Halczenko,David W. Cochran,Michael R. Dobrinska,William C. Vincek,(unknown),Stanley L. Gaul,Charles S. Sweet	39
18	Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats 1981 ·European Journal of Pharmacology ·Charles S. Sweet,(unknown),Stanley L. Gaul,Edward H. Blaine,Dennis M. Gross	35
19	Antagonism of conditioned salivation in conscious dogs by antihypertensive drugs 1977 ·Canadian Journal of Physiology and Pharmacology ·Charles S. Sweet,Stanley L. Gaul	4
20	Enhancement of the Humoral Response of T Cell-Depleted Murine Spleens by a Factor Derived from Human Monocytes in Vitro 1974 ·The Journal of Immunology ·David D. Wood,Stanley L. Gaul	64

About Stanley L. Gaul

Stanley L. Gaul is a scholar working on Hematology, Immunology and Allergy and Pharmaceutical Science, having authored 24 papers that have together received 871 indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (7 papers), Heparin-Induced Thrombocytopenia and Thrombosis (4 papers) and Neuroscience and Neuropharmacology Research (4 papers). The work is most often cited by research in Virology (216 citations), Infectious Diseases (242 citations) and Hematology (116 citations). Stanley L. Gaul has collaborated with scholars based in United States. Frequent co-authors include David D. Wood, Walfred S. Saari, Rodney A. Bednar, J C Quintero, J A O'Brien, Mark E. Goldman, John Wai, Jack H. Nunberg, William A. Schleif and J. M. HOFFMAN. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact